RALPH CINCINNATI: Open Payments
NPI 1174580716 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,377 in 117 payments from 20 companies in 2025. Trend: 2023 $1,745 · 2024 $2,491 · 2025 $2,377
Food & beverage: $2,377
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $340 |
| Novo Nordisk Inc | 13 | $274 |
| ABBVIE INC. | 13 | $271 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $156 |
| Lilly USA, LLC | 8 | $153 |
| Amgen Inc. | 18 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $113 |
| Mannkind Corporation | 4 | $112 |
| Corcept Therapeutics | 6 | $111 |
| Insulet Corporation | 3 | $111 |
Products named: FREESTYLE LIBRE 3, JARDIANCE, REPATHA, Wegovy, Ozempic, MOUNJARO, Kerendia, AFREZZA.
Industry payments across PA — which companies pay providers there.
